Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study aims to determine, in obese subjects, the antisecretory effect of a single dose of
placebo, rabeprazole 20 mg and omeprazole 20 mg using 24h gastric pH monitoring, in a
prospective, monocentre, randomized manner. Monitorings are separated between 6 and10 days.
The main outcome criteria of analysis is the percentage of time with gastric pH above 3
during 24hours.